Primary development: 3D-printed 'spanlastics' could change how cancer drugs reach tumors
Coverage synthesized from 1 sources in the cluster.
This draft should be editor-reviewed before publication.
Strategic angle: University of Mississippi research offers hope that cancer drug therapies packaged in 3D-printed carriers could deliver medication directly to tumors while reducing many of the side effects that cancer patients endure. I
Primary development: 3D-printed 'spanlastics' could change how cancer drugs reach tumors
Coverage synthesized from 1 sources in the cluster.
This draft should be editor-reviewed before publication.